id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-1909-0002,FDA,FDA-2023-D-1909,"Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act— Compliance Policies Guidance for Industry",Other,Guidance,2023-08-28T04:00:00Z,2023,8,2023-08-28T04:00:00Z,,2024-11-14T02:00:40Z,,1,0,0900006485f01540
FDA-2023-D-1909-0001,FDA,FDA-2023-D-1909,"Enhanced Drug Distribution Security Requirements Under Section 582(g)(1)
of the Federal Food, Drug, and Cosmetic Act—Compliance Policies; Guidance for Industry; Availability",Rule,Advance Notice of Proposed Rulemaking (ANPRM),2023-08-28T04:00:00Z,2023,8,,,2023-08-28T14:19:12Z,2023-18359,0,0,0900006485f00191